We are at the forefront of developing new treatments and therapies to stop, prevent and reverse liver disease

A shelf of beakers, chemicals and other research equipment

With a patient-centered approach, the Stravitz-Sanyal Institute will transform lives through translational science. Our team of highly specialized physician-scientists conducts cutting-edge investigations through bench research and clinical trials across a broad spectrum of diseases and conditions related to the liver.

Explore our researchers’ publications in the following areas:

As the institute grows, our next step is to apply gene manipulation therapy, a modern medical breakthrough, to bedside treatment for the liver without invasive surgery or medication. This advancement will have immediate benefits to patients here in the Richmond area and impact how we understand and treat the liver worldwide.

Featured Publications

Undiagnosed Cirrhosis in Veterans With Dementia

1 of 10 veterans diagnosed with dementia may instead have cognitive decline from cirrhosis.

It can be difficult for physicians to differentiate dementia from the cognitive decline caused by hepatic encephalopathy. If undetected, patients may not receive appropriate treatment that can reverse or halt the impairment. In JAMA Network Open, Jasmohan Bajaj, M.D., reports on the prevalence and risk factors of undiagnosed cirrhosis and potential encephalopathy in veterans with dementia. The results showed that as many as 10% of older U.S. veterans diagnosed with dementia may suffer instead from this reversible cognitive decline.

Current enrolling clinical trials

To learn more about clinical trials currently enrolling participants, visit VCU Health's Research and Clinical Trials webpage.

Current NIH-funded grants

To learn more about ongoing NIH-funded grants, select a team member below:

Support our research

Private donations empower top researchers to explore creative solutions. Sign our love letter to the liver by contributing to the Stravitz-Sanyal Institute.

Make a difference now